Allergen-specific immunotherapy offers the possibility of long-term desensitisation for atopic dogs, reducing chronic itch and dependence on symptomatic medications.
Allergen-specific immunotherapy offers the possibility of reducing chronic itch at an immune system level rather than merely controlling symptoms. For dogs with clearly identified environmental allergens, immunotherapy can provide sustained improvement that reduces dependence on lifelong symptomatic medication. The welfare benefit of genuine desensitisation is significant.